Skip to main content
. 2017 Jan 1;8(1):85–96. doi: 10.7150/jca.16792

Table 2.

Registered trials of mesenchymal stem cells (MSCs) in anticancer therapies.

Disease Source of MSCs Phase Status Registered ID
Advanced ovarian cancer Allogeneic bone marrow 1 Not yet recruiting NCT02530047
Localized prostate cancer Allogeneic bone marrow 1 Recruiting NCT01983709
Head and neck cancer N/A 1 Not yet recruiting NCT02079324
Recurrent ovarian cancer Adipose tissue 1/2 Not yet recruiting NCT02068794
Metastatic and refractory tumors. Autologous bone marrow 1/2 Not yet recruiting NCT01844661
Hematologic malignancies Third-party bone marrow 1/2 Recruiting NCT01092026
Hematologic malignancies Allogeneic bone marrow Not provided Recruiting NCT02181478

Note: The trials are registered at ClinicalTrials.gov. Search performed on October 28th, 2015.